Literature DB >> 632599

A simplified procedure for cyclic nucleotide radioimmunoassay and its application to human blood leukocytes.

G E Hatch, W K Nichols, H R Hill.   

Abstract

Rapid treatment of leukocyte suspensions was found to be an effective alternative to acid treatment in the preparation of these cells for radioimmunoassay of cyclic GMP and cyclic AMP. A 2-sec heating to boiling temperature, followed by sonication and micropore filtration, was employed. This procedure adequately inactivated or removed enzymes and binding proteins that can alter cyclic nucleotide concentrations or otherwise interfere with the radioimmunoassay. Moreover, heating in this manner did not appear to affect the stability of cyclic nucleotides or cause significant formation of cyclic GMP from endogenous GTP. Recovery of cyclic nucleotides after heating and filtration was high (89-96%), making possible the measurement of both cyclic GMP and cyclic AMP in small cellular samples. Variation in cyclic nucleotide recovery was small (+/- 2-4% SD), therefore individual recovery determinations were unnecessary.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 632599     DOI: 10.1016/0022-1759(78)90014-5

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  3 in total

1.  Chemotaxin-induced changes in cyclic adenosine monophosphate levels in human neutrophils.

Authors:  R S Marx; C E McCall; D A Bass
Journal:  Infect Immun       Date:  1980-07       Impact factor: 3.441

2.  Stimulus-specific deactivation of chemotactic factor-induced cyclic AMP response and superoxide generation by human neutrophils.

Authors:  L Simchowitz; J P Atkinson; I Spilberg
Journal:  J Clin Invest       Date:  1980-10       Impact factor: 14.808

3.  Histamine regulates lymphocyte mitogenic responses through activation of specific H1 and H2 histamine receptors.

Authors:  B E Ogden; H R Hill
Journal:  Immunology       Date:  1980-09       Impact factor: 7.397

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.